EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Metformin Use in the First Trimester of Pregnancy and Risk for Nonlive Birth and Congenital Malformations: Emulating a Target Trial Using Real-World Data

Yu-Han Chiu iD, Krista F Huybrechts iD, Elisabetta Patorno, Jennifer J Yland iD, Carolyn E Cesta iD, Brian T Bateman, Ellen W Seely iD, Miguel A Hernán iD, Sonia Hernández-Díaz iD

Annals of Internal Medicine · 2024

DOI: 10.7326/m23-2038 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Annals of Internal Medicine, 2024. Verfasst von Yu-Han Chiu und 8 weiteren Autor:innen. Beteiligte Einrichtung: CAUSALab and Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (Y.-H.C., S.H.). Hauptthemen laut MEDLINE: Metformin, Pregnancy Trimester, First, Hypoglycemic Agents, Abnormalities, Drug-Induced. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminPregnancy Trimester, FirstHypoglycemic AgentsAbnormalities, Drug-InducedDiabetes Mellitus, Type 2InsulinPregnancy in DiabeticsHumansFemalePregnancyAdultDrug Therapy, CombinationUnited StatesRisk Factors

Substanzen

MetforminHypoglycemic AgentsInsulin

Autor:innen und Institutionen

  • CAUSALab and Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (Y.-H.C., S.H.).
  • Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (K.F.H., E.P.).
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts (J.J.Y.).
  • Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden (C.E.C.).
  • Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, Department of Anesthesiology, Perioperative and Pain Medici…
  • Endocrinology, Diabetes and Hypertension Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (E.W.S.).

ORCID-Profile: Yu-Han Chiu, Krista F Huybrechts, Jennifer J Yland, Carolyn E Cesta, Ellen W Seely, Miguel A Hernán, Sonia Hernández-Díaz

Förderung

  • NICHD NIH HHS

Zitieren

APA

Chiu, Y. H., Huybrechts, K. F., Patorno, E., Yland, J. J., Cesta, C. E., Bateman, B. T., Seely, E. W., Hernán, M. A., & Hernández-Díaz, S. (2024). Metformin Use in the First Trimester of Pregnancy and Risk for Nonlive Birth and Congenital Malformations: Emulating a Target Trial Using Real-World Data. Annals of Internal Medicine. https://doi.org/10.7326/m23-2038

Vancouver

Chiu YH, Huybrechts KF, Patorno E, Yland JJ, Cesta CE, Bateman BT, et al. Metformin Use in the First Trimester of Pregnancy and Risk for Nonlive Birth and Congenital Malformations: Emulating a Target Trial Using Real-World Data. Annals of Internal Medicine. 2024. doi:10.7326/m23-2038

BibTeX
@article{Chiu2024,
  author = {Chiu, Yu-Han and Huybrechts, Krista F and Patorno, Elisabetta and Yland, Jennifer J and Cesta, Carolyn E and Bateman, Brian T and Seely, Ellen W and Hernán, Miguel A and Hernández-Díaz, Sonia},
  title = {Metformin Use in the First Trimester of Pregnancy and Risk for Nonlive Birth and Congenital Malformations: Emulating a Target Trial Using Real-World Data},
  journal = {Annals of Internal Medicine},
  year = {2024},
  doi = {10.7326/m23-2038}
}
Kostenlos starten →